2019 Gastrointestinal Stromal Tumor (GIST) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 139 pages | ID: 2A2283F4643EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Gastrointestinal Stromal Tumor (GIST) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Gastrointestinal Stromal Tumor (GIST). It presents in-depth analysis of Gastrointestinal Stromal Tumor (GIST) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Gastrointestinal Stromal Tumor (GIST).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Gastrointestinal Stromal Tumor (GIST) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Gastrointestinal Stromal Tumor (GIST)

The research work is prepared through extensive and continuous research on Gastrointestinal Stromal Tumor (GIST) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Gastrointestinal Stromal Tumor (GIST) patients are identified
• The report includes panorama of Gastrointestinal Stromal Tumor (GIST) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Gastrointestinal Stromal Tumor (GIST) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Gastrointestinal Stromal Tumor (GIST) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Region
  2.2.2 Average Enrollment of Gastrointestinal Stromal Tumor (GIST) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Gastrointestinal Stromal Tumor (GIST) Treatment, 2019

3. REGION WISE GASTROINTESTINAL STROMAL TUMOR (GIST) CLINICAL TRIALS

3.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country
3.2 Europe Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country
3.3 North America Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country
3.4 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country
3.5 South and Central America Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country

4. GASTROINTESTINAL STROMAL TUMOR (GIST) CLINICAL TRIAL TRENDS

4.1 Start Year wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials
4.2 Phase wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials
4.3 Trial Status wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials
4.4 Trial Type wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials

5. GASTROINTESTINAL STROMAL TUMOR (GIST) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Gastrointestinal Stromal Tumor (GIST) Trials by Year
5.2 Average Enrollment in Gastrointestinal Stromal Tumor (GIST) Trials by Phase
5.3 Average Enrollment in Gastrointestinal Stromal Tumor (GIST) Trials by Status
5.4 Average Enrollment in Gastrointestinal Stromal Tumor (GIST) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN GASTROINTESTINAL STROMAL TUMOR (GIST) CLINICAL TRIALS

6.1 Gastrointestinal Stromal Tumor (GIST) Trials by Sponsor Type
6.2 Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Gastrointestinal Stromal Tumor (GIST) Trials- Phase
7.2 Gastrointestinal Stromal Tumor (GIST) Trials- Phase
7.3 Gastrointestinal Stromal Tumor (GIST) Trials- Phase
7.4 Gastrointestinal Stromal Tumor (GIST) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 7: North America – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 9: Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Phase
Figure 10: Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Trial Status
Figure 11: Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Type
Figure 12: Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Sponsor Type
Figure 13: Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Leading Sponsors
Figure 14: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Phase
Figure 15: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Trial Status
Figure 16: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Type
Figure 17: Gastrointestinal Stromal Tumor (GIST)- Average Enrolment by Type of Sponsors
Figure 18: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Gastrointestinal Stromal Tumor (GIST) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 5: Europe – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 7: North America – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Phase
Table 15: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Trial Status
Table 16: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Type
Table 17: Gastrointestinal Stromal Tumor (GIST)- Average Enrolment by Type of Sponsors
Table 18: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Leading Sponsors